[Federal Register Volume 70, Number 9 (Thursday, January 13, 2005)]
[Notices]
[Pages 2407-2410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-488]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement Open Season 02060-FY05]


National Cancer Prevention and Control Program; Notice of 
Availability of Open Season Funds

    LOI Deadline: January 28, 2005.
    Application Deadline: February 28, 2005.

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2005 funds for an Open Season for the 
National Cancer Prevention and Control Program (NCPCP) cooperative 
agreement program previously announced under Program Announcement 02060 
(Henceforth referred to as ``PA 02060''). This program addresses the 
``Healthy People 2010'' focus area(s) related to cancer.
    PA02060 was published in the Federal Register on April 23, 2002, 
Volume 67, Number 78, pages 19932-19950. Amendment 1 was published May 
23, 2002, Amendment 2 was published January 2, 2003, and Amendment 3 
was published on January 20, 2004. Applicants may access the amended 
version of PA 02060, along with this Open Season announcement, on the 
CDC Web site, Internet address: http://www.cdc.gov. Click on 
``Funding,'' then ``Grants and Cooperative Agreements.''
    Sections A.-F. of original PA 02060 are superceded by the Sections 
A.-F. published in this announcement.
    The NCPCP will assist States/District of Columbia/Tribes/
Territories in developing, implementing, maintaining, enhancing, 
integrating, and evaluating a cancer program inclusive of cancer 
surveillance, prevention and early detection programs, and which 
focuses on eliminating health disparities. The purpose of each of the 
three programmatic components within the NCPCP follows.

A.1. National Comprehensive Cancer Control Programs (NCCCP)

    The NCCCP component supports the planning and implementation of

[[Page 2408]]

comprehensive cancer control activities. CDC defines comprehensive 
cancer control as an integrated and coordinated approach to reduce the 
incidence, morbidity and mortality of cancer through prevention, early 
detection, treatment, rehabilitation, and palliation.

A.2. National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP)

    The NBCCEDP component supports the development of systems to assure 
breast and cervical cancer screening for low income, underserved, and 
uninsured women with special emphasis on reaching those who are 
geographically or culturally isolated, older, or members of racial/
ethnic minorities. Components of the NBCCEDP include program 
management; screening & diagnostic services, to include case 
management, tracking and follow-up; data management; quality assurance/
quality improvement; evaluation; partnerships; professional development 
and recruitment, to include public education, outreach and inreach. 
These components are carried out at the local, State and national 
levels through collaborative partnerships with State health agencies, 
community-based organizations, tribal governments, universities, a 
variety of medical care providers and related agencies and 
institutions, and the business and voluntary sectors. These partners 
work together to develop, implement and evaluate strategies to promote 
breast and cervical cancer prevention and early detection, to increase 
access to related services and to improve the quality and timeliness of 
the services.

A.3. National Program of Cancer Registries (NPCR)

    The NPCR component supports efforts to establish population-based 
cancer registries where they do not exist and to improve existing 
cancer registries.
    PA 02060 and applicable amendments, contain information that is 
specific to the three individual components. Section G ``Specific 
Guidance for NCCCP'' addresses the National Comprehensive Cancer 
Control Program; Section H ``Specific Guidance for NCCEDP'' addresses 
the National Breast and Cervical Cancer Early Detection Program; and 
Section I ``Specific Guidance for NPCR'' addresses the National Program 
of Cancer Registries. These component sections include specific 
guidance regarding:
     Eligibility
     Program Requirements
     Content
     Other Requirements
     Evaluation Criteria
    Please refer to these specific component sections in PA 02060, and 
amendments for information.
Special Guidelines for Technical Assistance
    Conference Call: Technical assistance will be available for 
potential applicants on a conference call that will be held on January 
19, 2005, from 3:30 p.m. to 5:30 p.m. (Eastern time). Potential 
applicants are requested to call in using only one telephone line. The 
conference can be accessed by calling 1-888-576-9873, and entering the 
passcode 21028.
    The purpose of the conference call is to help potential applicants 
to:
    1. Understand the process for the Open Season Announcement for PA 
02060 for the National Cancer Prevention and Control Program;
    2. Understand the scope and intent of PA 02060 for the National 
Cancer Prevention and Control Program;
    3. Be familiar with the Public Health Services funding policies and 
application and review procedures.
    Participation in this conference call is not mandatory. At the time 
of the call, if you have problems accessing the conference call, please 
call 404-639-7550.

B. Eligible Applicants

    Applicants may apply for any or all of the components within this 
Open Season announcement for which they are eligible and that they are 
not currently funded for under PA 02060.

B.1. Eligible for NCCCP

    Potential applicants that are eligible for components of NCCCP are 
the health departments of States or their bona fide agents, the 
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of 
the Northern Mariana Islands, American Samoa, Guam, the Federated 
States of Micronesia, the Republic of the Marshall Islands, and 
Federally recognized Indian Tribal governments and Tribal 
organizations, urban Indian organizations and inter-tribal consortia 
(hereafter referred to as Tribes) whose primary purpose is to improve 
American Indian/Alaska Native health and which represent the Native 
population in their catchment area, that are not currently funded for 
NCCCP under PA 02060.

B.2. Eligible for NBCCEP

    Potential applicants that are eligible for NBCCEDP are the Virgin 
Islands, the Commonwealth of the Northern Mariana Islands, the 
Federated States of Micronesia, the Republic of the Marshall Islands, 
and Federally recognized Indian Tribal governments and Tribal 
organizations, urban Indian organizations and inter-tribal consortia 
(hereafter referred to as Tribes) whose primary purpose is to improve 
American Indian/Alaska Native health and which represent the Native 
population in their catchment area, that are not currently funded for 
NBCCEDP under PA 02060.

B.3. Eligible for NPCR

    Potential applicants that are eligible for components of NPCR are 
the health departments of States or their bona fide agents, the 
Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the 
Federated States of Micronesia, the Republic of the Marshall Islands, 
and academic or nonprofit organizations designated by a State to 
operate the State's cancer registry, that are not currently funded 
under PA 02060.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

C. Availability of Funds

    Pending availability of FY 2005 funds, approximately $1,850,000 is 
available in FY 2005 to fund new programs under the Open Season for PA 
02060-FY05.
    Awards under PA 02060 were made for a Project Period of September 
30, 2002 through June 29, 2007. The first funding period was for the 
period September 30, 2002 through June 29, 2003. The second funding 
period was for the period June 30, 2003 through June 29, 2004. The 
third funding period was for the period June 30, 2004 through June 29, 
2005. Awards under this Open Season announcement will be for the Period 
of June 30, 2005 through June 29, 2007, with funding for the period 
June 30, 2005 through June 29, 2006. Future budget periods will be 12-
month periods, and will begin on June 30 of every year and run through 
June 29 of each following year. These budget periods will occur until 
the expiration of the project period for PA 02060, which is June 29, 
2007.
    In Accordance with G.2.d. of PA 2060, Amendment 4, there will be no 
funding preferences applicable to this funding period.
    All new applications will be reviewed through an Objective Review 
process.

C.1. Component Funding

NCCCP $250,000
NBCCEDP $0 (No Open Season Funds Available for FY05)

[[Page 2409]]

NPCR $250,000

    NCCCP--Additional Optional Funding available for recipients of 
NCCCP Implementation Programs as follows:

Colorectal cancer activities $250,000
Ovarian cancer activities $500,000
Prostate cancer activities $500,000
Skin cancer activities $100,000

C.2. Requested Budget Information

    Applicants should submit separate budgets for each component (as 
well as separate budgets if applying for the Additional Optional 
Funding under NCCCP) in response to this Open Season announcement. Each 
detailed budget and narrative justification should support the 
activities for the funding period specified in this Program 
Announcement for FY 2005 support.
    Applications should follow the guidance provided under each program 
component in PA 02060 and applicable amendments, with respect to the 
development and submission of an itemized budget and justification.

C.3. Use of Funds

    For specific ``Use of Funds'' information, refer to Sections G, H, 
and I of PA 02060 and amendments.
    Cooperative agreement funds may be used to support personnel and to 
purchase equipment, supplies, and services directly related to project 
activities and consistent with the scope of the cooperative agreement.
    Funds provided under this program announcement may not be used to:
     Conduct research projects. Guidance regarding CDC's 
definition of ``research'' should be reviewed at http://www.cdc.gov/od/ads/opspoll1.htm.
     Supplant State or local funds, to provide inpatient care 
or treatment, or to support the construction or renovation of 
facilities.
    Applicants are encouraged to identify and leverage mutually 
beneficial opportunities to interact and integrate with other State 
health department programs that address related chronic diseases or 
risk factors. This may include cost sharing to support a shared 
position such as a Chronic Disease Epidemiologist, Health Communication 
Specialist, Program Evaluator, or Policy Analyst to work on relevant 
activities across units/departments within the State health department. 
Such activities may include, but are not limited to joint planning, 
joint funding of complementary activities, public health education, 
collaborative development and implementation of environmental, policy, 
systems, or community interventions and other cost sharing activities.

C.4. Recipient Financial Participation

    For specific ``Recipient Financial Participation'' information, 
please refer to Sections G, H, and I of PA 02060 and amendments.

C.5. Direct Assistance

    For specific ``Direct Assistance'' information, please refer to 
Sections G, H, and I of PA 02060 and amendments.

C.6. Funding Preferences

    In accordance with the ``Funding Preference'' section of the 
amended PA 02060, no funding preference will be given for this period. 
For specific ``Funding Preference'' information, please refer to 
Sections G, H, and I of PA 02060 and amendments.

C.7. Funding Consideration

    For specific ``Funding Consideration'' information, please refer to 
Sections G, H, and I of PA 02060 and amendments.

D. Content

D.1. Letter of Intent

    One Letter of Intent (LOI) is requested from each applicant 
applying for any component(s) of this program. The narrative should be 
no more than one single-spaced page, printed on one side, with one-inch 
margins, and unreduced font. Your LOI will not be evaluated, but will 
be used to assist CDC in planning for the objective review for this 
program and should include the announcement number, the specific 
component(s) and parts of the component, if applicable, for which funds 
are being applied, and the name of the principal investigator.

D.2. Application Development

    Please refer to Sections G, H, and I of PA 02060 and amendments to 
use the information in the Program Requirements, Other Requirements, 
and Evaluation Criteria sections to develop the application content. 
Your application will be evaluated using the criteria listed, so it is 
important to follow them in laying out your application.
    Applications should follow the guidance below with respect to page 
limitations for each component. All applications should be printed on 
one side, with one-inch margins, using unreduced font. All materials 
must be provided in an unbound, one-sided, 8\1/2\ x 11'' print format, 
suitable for photocopying (i.e., no audiovisual materials, posters, 
tapes, etc.).

D.3. Page Limitations

    For specific ``Page Limitations'' information, please see Sections 
G, H, and I of PA 02060 and amendments.

D.4. Application Outline

    Applicants may apply for any or all of the components within this 
program announcement for which they are eligible. Please provide 
specific ``Application Outline'' information for each component as 
outlined in specific Sections G, H, and I of PA 02060 and amendments.

E. Submission and Deadline

E1. Letter of Intent

    On or before January 28, 2004, submit the LOI to the National 
Center for Chronic Disease Prevention and Control.
    By mail: Tanya Hicks, Program Analyst, CDC National Center for 
Chronic Disease Prevention and Health Promotion, 4770 Buford Hwy, NE, 
MS K-57, Atlanta, GA 30341-3717; or by courier service: Tanya Hicks, 
Koger Center, 2858 Woodcock Blvd, Davidson Bldg, Room 2081, Chamblee, 
GA 30341; or by fax: 770-488-3230; or by e-mail: [email protected].

E.2. Application

    Submit the original and two copies of CDC Form 0.1246. Forms are 
available in the application kit and at the following Internet address: 
www.cdc.gov/od/pgo/forminfo.htm.
    On or before February 28, 2005, submit the original and two copies 
of the application to: Technical Information Management--PA02060FY05, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention, 2920 Brandywine Road, Atlanta, GA 30341-4146.
    Applications may not be submitted electronically at this time.
    Please reference Program Announcement Number 02060-FY05 National 
Cancer Prevention and Control Program on the mailing envelope and on 
the application Standard Form 424, block 11. Please also make sure that 
block 16 on Standard Form 424 regarding Executive Order 12372 has been 
completed correctly.

E.3. Deadline

    Applications must be received in the CDC Procurement and Grants 
Office by 4 p.m. Eastern time on the deadline date. If you send your 
application by the United States Postal Service of commercial delivery 
service, you must ensure that the carrier will be able to guarantee 
delivery of the application by the closing date and time. If CDC 
receives your application after closing due to: (1) Carrier error, when 
the carrier accepted the package with a guarantee for delivery by the 
closing date and time, or (2) significant weather delays or natural 
disasters, you will be

[[Page 2410]]

given the opportunity to submit documentation of the carriers 
guarantee. If the documentation verifies a carrier problem, CDC will 
consider the application as having been received by the deadline.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for the applications to 
be processed and logged.

F. Evaluation Criteria

    Each application will be evaluated individually will be reviewed 
through an Objective Review process.
    For specific ``Evaluation Criteria'' information, please see 
Sections G, H, and I of PA 02060 and amendments.

G. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address--http://www.cdc.gov. Click on ``Funding'' then 
``Grants and Cooperative Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance in the states may 
be obtained from: Annie Camacho or Glynnis Taylor, Grants Management 
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341-4146, Telephone number: Annie Camacho: 770-488-2735, 
Glynnis Taylor: 770-488-2752, E-mail address: Annie Camacho: 
[email protected], Glynnis Taylor: [email protected].
    Business management technical assistance in the territories may be 
obtained from: Vincent Falzone, Grants Management Specialist, CDC 
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341-
4146, Telephone number: 770-488-2763, E-mail address: [email protected].
    For program technical assistance contact:
    NCCCP: Leslie S. Given, M.P.A., Public Health Advisor, NCCCP, 
Program Services Branch, Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion, 
Centers for Disease Control and Prevention, 4770 Buford Hwy., NE (MS K-
57), Atlanta, GA 30341-3717, Telephone number: 770-488-3099, E-mail 
address: [email protected].
    NBCCEDP: Susan True, M.Ed., Branch Chief, Program Services Branch, 
Division of Cancer Prevention and Control, National Center for Chronic 
Disease Prevention and Health Promotion, Centers for Disease Control 
and Prevention, 4770 Buford Hwy., NE (MS K-57), Atlanta, GA 30341-3717, 
Telephone number: 770-488-4880, E-mail address: [email protected].
    NPCR: Lois Voelker, Public Health Advisor, Cancer Surveillance 
Branch, Division of Cancer Prevention and Control, National Center for 
Chronic Disease Prevention and Health Promotion, Centers for Disease 
Control and Prevention, 4770 Buford Hwy., NE (MS K-53), Atlanta, GA 
30341-3717, Telephone number: 770-488-3095, E-mail address: 
[email protected].

    Dated: January 5, 2005.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-488 Filed 1-12-05; 8:45 am]
BILLING CODE 4163-18-P